Companies › Joint Biosciences
Joint Biosciences: clinical trials, targets and expected readouts
1 active drug program in 1 registered trial: 1 Phase 1; Oncology; next expected readout Apr 2027.
Open in Phaseline: competitors, likelihood bands and readouts Company report
Programs Drug Target Highest phase Conditions Next expected readout OVV-01 Injection oncolytic virus
– Phase 1 Advanced Solid Tumors Apr 2027
Trials Registry id Drug Phase Conditions Area Expected readout NCT07648472 OVV-01 Injection Phase 1 Advanced Solid Tumors Oncology Apr 2027
From the company's SEC filings Cash of $18m on 2026-09-30; operating cash flow positive
Press releases filed as 8-K in the last year:
Agreements filed with the SEC (item 1.01), last two years 2026-10-01 · collaboration with The Joint Franchises San Antonio, LLC · On October 1, 2026, we entered into an Asset Purchase Agreement (the “APA”) with The Joint Franchises San Anto 2026-04-24 · acquisition · On April 20, 2026, we entered into an Asset Purchase Agreement (the “Elite Chiro Group Purchase Agreement”) wi 2026-01-09 · agreement with Bandera Partners LLC · On January 5, 2026, we entered into a letter of agreement (the “Letter Agreement”) with Bandera Partners LLC a 2025-12-11 · acquisition with Addisco Value, LLC · On December 5, 2025, we entered into an Asset Purchase Agreement (as amended, the “Southeast Purchase Agreemen 2025-11-06 · collaboration · On November 2, 2025, we entered into an Asset Purchase Agreement (the “Elite Chiro Group Purchase Agreement”) 2025-06-27 · acquisition with Joint Ventures, LLC · . On June 23, 2025, we entered into an Asset Purchase Agreement (the “Joint Ventures Purchase Agreement”) with
Targets No annotated target.
Companies with the same targets –
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.
Built from ClinicalTrials.gov, CTIS, FDA, PubMed and OpenAlex, read every week; this page from the landscape of 2026-11-09. Phaseline reads registries; it is not investment or medical advice. Method and sources · Privacy · Contact